Learn why and how the Accelerated Access Collaborative supports stronger NHS adoption and spread of biologic therapies for the treatment of severe asthma as part of the Rapid Uptake Product Programme.

• This session will provide a high-level overview of:
• - the products selected for support to help improve the treatment of severe asthma;
• - the priorities the collaborative partners are pursuing to remove barriers to their uptake; and
• - the progress currently being made in this area.